Moxcon-CV 625LB Tablet is a broad-spectrum antimicrobial agent indicated for the treatment of various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and urinary tract infections. The formulation consists of a fixed-dose combination of Amoxycillin (500mg) and Cloxacillin (125mg), which provides a synergistic effect against a wide range of Gram-positive and Gram-negative bacteria. Additionally, the tablet contains Lactobacillus (60 million spores), a probiotic strain that helps maintain the balance of gut flora. The antibiotic combination of Amoxycillin and Cloxacillin offers a broad spectrum of antimicrobial activity, effectively targeting Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli, and Staphylococcus aureus, among others. The probiotic component, Lactobacillus, supports the restoration of the natural balance of gut flora, thereby minimizing the risk of antibiotic-associated gastrointestinal disturbances. Moxcon-CV 625LB Tablet is contraindicated in patients with a history of hypersensitivity to any of its components, and its use should be guided by the product's labeling and accepted medical practices.